Florida’s medical marijuana market brought in $161,736,755 in sales during the month of April, according to data released by research firm Headset.
This brings the state’s 2025 total to over $610 million, solidifying Florida’s role as the largest medical-only marijuana market in the United States. Headset revised the sales total for March, lowering the total slightly from $162 million to $159 million.
Dried marijuana flower continued to dominate Florida’s medical market in April, making up the largest portion of sales at approximately 45%. Vapor pens, edibles, concentrates, pre-rolls, capsules, and tinctures and topicals followed in that order, reflecting consistent trends from previous months.
As of early May, there are 911,957 registered medical marijuana patients in Florida, an increase of more than 11,000 since the start of the year and over 30,000 more than this time last year, according to the Florida Department of Health.
Florida’s medical marijuana program was established through the passage of Amendment 2 in 2016. Patients with qualifying conditions can access a variety of marijuana products through licensed dispensaries with approval from a certified physician.
The state may soon see a broader expansion, as a proposed 2026 ballot initiative backed by Smart & Safe Florida would legalize recreational marijuana. Recent polling suggests 67% of Florida voters support the measure.
